Autopsy report · NCT00756106

MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Glioma

“Funding ended”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months after it had already started.
• Ran for about 3 years 7 months before it stopped.
• 15 participants enrolled.
• Results were posted on the registry 8 years 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Massachusetts General Hospital

Sponsor type

University, hospital or other

Conditions

Brain and Central Nervous System Tumors

Interventions

temozolomide; Imaging biomarker analysis; Photon Radiation Therapy

Participants

15

Sites

1

Countries

United States

Trials that died the same way

• Observational Study of the Effect of Ozanimod on Fatigue in Multiple Sclerosis Patients
  “Funding ended prematurely” (92% match in meaning)
• Evaluation of a Novel Microfluidic Device to Purify Metastatic Lung Cancer Patients CTC (Circulating Tumoral Cells)
  “funding ending” (91% match in meaning)
• Role of FCI in the Detection of Proctosigmoiditis Caused by IBD
  “Funding period ended” (89% match in meaning)
• A Study of APR-246 in Oesophageal Cancer
  “Funding ceased” (88% match in meaning)
• Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventional Catheter
  “Funding Stopped” (87% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.